|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Fanconi's Anemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Anemia | |||||
| Fanconi Anemia | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia, Aplastic | |||||
| Anemia, Hypoplastic, Congenital | |||||
| Bone Marrow Diseases | |||||
| DNA Repair-Deficiency Disorders | |||||
| Genetic Diseases, Inborn | |||||
| Hematologic Diseases | |||||
| Metabolic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| amifostine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Radiation-Protective Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| Dana-Farber Cancer Institute | |||||